Literature DB >> 19121670

Burkholderia pseudomallei: animal models of infection.

Richard W Titball1, Paul Russell, Jon Cuccui, Anna Easton, Ashraful Haque, Tim Atkins, Mitali Sarkar-Tyson, Vicki Harley, Brendan Wren, Gregory J Bancroft.   

Abstract

A range of animal models of Burkholderia pseudomallei infection have been reported, and the host species differ widely both in their susceptibility to infection and in the pathogenesis of disease. In mice, and depending on the route of infection, dose, and mouse strain, the disease can range from a chronic, and in some cases, an apparently latent infection to an acute fulminant disease. Alternative small animal models of infection include diabetic rats or hamsters. Larger animal models of disease have not yet been fully developed. It is not clear which of the small animal models of melioidosis most accurately reflect disease in humans. However, the findings that diabetic rats are susceptible to infection, that some strains of mice can develop persistent subclinical infections that can spontaneously reactivate, and that inhalation exposure generally results in more acute disease suggest that these different models mimic different aspects of human melioidosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19121670     DOI: 10.1016/S0035-9203(08)70026-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  50 in total

1.  Dissecting novel virulent determinants in the Burkholderia cepacia complex.

Authors:  George P Tegos; Mark K Haynes; Herbert P Schweizer
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

2.  Cloning, purification, crystallization and preliminary X-ray analysis of the Burkholderia pseudomallei L1 ribosomal protein.

Authors:  Abd Ghani Abd Aziz; Sergey N Ruzheinikov; Svetlana E Sedelnikova; Rahmah Mohamed; Sheila Nathan; Patrick J Baker; David W Rice
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-02-22

3.  Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity.

Authors:  Claudia M Müller; Laura Conejero; Natasha Spink; Matthew E Wand; Gregory J Bancroft; Richard W Titball
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 4.  Novel multi-component vaccine approaches for Burkholderia pseudomallei.

Authors:  L Morici; A G Torres; R W Titball
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

5.  Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice.

Authors:  T Eoin West; Nicolle D Myers; Direk Limmathurotsakul; H Denny Liggitt; Narisara Chantratita; Sharon J Peacock; Shawn J Skerrett
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

6.  Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosis.

Authors:  Laura Conejero; Natasha Patel; Melanie de Reynal; Sara Oberdorf; Joanne Prior; Philip L Felgner; Richard W Titball; Francisco J Salguero; Gregory J Bancroft
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

7.  A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy.

Authors:  John R North; Shunsuke Takenaka; Annett Rozek; Agnieszka Kielczewska; Steven Opal; Lisa A Morici; B Brett Finlay; Christopher J Schaber; Richard Straube; Oreola Donini
Journal:  J Biotechnol       Date:  2016-03-23       Impact factor: 3.307

8.  Flagellar glycosylation in Burkholderia pseudomallei and Burkholderia thailandensis.

Authors:  Andrew E Scott; Susan M Twine; Kelly M Fulton; Richard W Titball; Angela E Essex-Lopresti; Timothy P Atkins; Joann L Prior
Journal:  J Bacteriol       Date:  2011-05-20       Impact factor: 3.490

9.  The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice.

Authors:  Michael H Norris; Katie L Propst; Yun Kang; Steven W Dow; Herbert P Schweizer; Tung T Hoang
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

10.  Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.

Authors:  Samantha J Dando; Deepak S Ipe; Michael Batzloff; Matthew J Sullivan; David K Crossman; Michael Crowley; Emily Strong; Stephanie Kyan; Sophie Y Leclercq; Jenny A K Ekberg; James St John; Ifor R Beacham; Glen C Ulett
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.